US Stock MarketDetailed Quotes

PHIO Phio Pharmaceuticals

Watchlist

2.2100
-0.0200-0.90%

Close Nov 15 16:00 ET

2.2100
0.00000.00%

Post 20:01 ET

2.33MMarket Cap-226P/E (TTM)

Phio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

35.87%-1.78M

25.74%-2.01M

11.38%-10.75M

12.38%-2.37M

17.75%-2.9M

-14.08%-2.77M

21.94%-2.71M

-2.29%-12.13M

-9.47%-2.71M

-23.03%-3.53M

Net income from continuing operations

27.58%-1.85M

40.20%-2.15M

5.70%-10.83M

30.61%-1.9M

22.26%-2.78M

-0.71%-2.55M

-36.34%-3.6M

13.60%-11.48M

20.86%-2.73M

4.44%-3.58M

Operating gains losses

--0

--3K

----

Depreciation and amortization

-97.87%1K

-27.66%34K

-4.66%184K

-6.52%43K

2.17%47K

-4.08%47K

-9.62%47K

0.52%193K

-66.42%46K

142.11%46K

Change In working capital

114.60%53K

-89.95%74K

57.32%-536K

-953.23%-653K

-158.59%-256K

-1,110.00%-363K

169.11%736K

-226.87%-1.26M

-107.83%-62K

-114.45%-99K

-Change in prepaid assets

38.44%-221K

46.18%459K

-2,550.00%-196K

-82.89%39K

-124.42%-190K

21.96%-359K

158.36%314K

-96.68%8K

-9.16%228K

-2.75%778K

-Change in payables and accrued expense

813.33%274K

-177.09%-350K

82.00%-205K

-154.65%-657K

96.21%-32K

-93.49%30K

191.35%454K

-231.68%-1.14M

-146.07%-258K

-1,026.67%-845K

-Change in other current liabilities

--0

-9.38%-35K

-8.00%-135K

-9.38%-35K

-6.25%-34K

-9.68%-34K

-6.67%-32K

-7.76%-125K

-68.42%-32K

20.00%-32K

Cash from discontinued investing activities

Operating cash flow

35.87%-1.78M

25.74%-2.01M

11.38%-10.75M

12.38%-2.37M

17.75%-2.9M

-14.08%-2.77M

21.94%-2.71M

-2.29%-12.13M

-9.47%-2.71M

-23.03%-3.53M

Investing cash flow

Cash flow from continuing investing activities

95.87%-5K

-137.25%-121K

76.67%-7K

Net PPE purchase and sale

----

95.87%-5K

--0

----

-137.25%-121K

--0

76.67%-7K

Cash from discontinued investing activities

Investing cash flow

----

95.87%-5K

--0

----

-137.25%-121K

--0

76.67%-7K

Financing cash flow

Cash flow from continuing financing activities

89.47%-4K

28,611.54%7.41M

120,050.00%2.4M

5.05M

-52.00%-38K

-100.12%-26K

300.00%2K

-3K

Net common stock issuance

--0

--7.44M

--2.4M

--0

--5.05M

---11K

--0

Net preferred stock issuance

--0

-200.00%-2K

--0

---2K

--2K

--0

Net other financing activities

--0

84.00%-4K

7.14%-26K

---1K

--0

0.00%-25K

-2,700.00%-28K

--0

---3K

Cash from discontinued financing activities

Financing cash flow

--0

89.47%-4K

28,611.54%7.41M

120,050.00%2.4M

--0

--5.05M

-52.00%-38K

-100.12%-26K

300.00%2K

---3K

Net cash flow

Beginning cash position

-28.73%6.48M

-28.24%8.49M

-50.92%11.83M

-41.81%8.46M

-37.15%11.36M

-55.70%9.09M

-50.92%11.83M

68.65%24.11M

-45.32%14.53M

-38.69%18.07M

Current changes in cash

-178.21%-1.78M

26.62%-2.02M

72.78%-3.34M

101.22%33K

17.99%-2.9M

193.15%2.27M

23.68%-2.75M

-225.10%-12.28M

-9.34%-2.7M

-22.10%-3.54M

End cash Position

-58.63%4.7M

-28.73%6.48M

-28.24%8.49M

-41.81%8.46M

-37.15%11.36M

-55.70%9.09M

-50.92%11.83M

-45.32%14.53M

Free cash flow

35.99%-1.78M

25.74%-2.01M

12.21%-10.75M

12.38%-2.37M

17.92%-2.9M

-13.82%-2.78M

24.21%-2.71M

-2.86%-12.25M

-9.47%-2.71M

-22.00%-3.53M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	35.87%-1.78M	25.74%-2.01M	11.38%-10.75M	12.38%-2.37M	17.75%-2.9M	-14.08%-2.77M	21.94%-2.71M	-2.29%-12.13M	-9.47%-2.71M	-23.03%-3.53M
Net income from continuing operations	27.58%-1.85M	40.20%-2.15M	5.70%-10.83M	30.61%-1.9M	22.26%-2.78M	-0.71%-2.55M	-36.34%-3.6M	13.60%-11.48M	20.86%-2.73M	4.44%-3.58M
Operating gains losses	--0	--3K	----	----	----	----	----	----	----	----
Depreciation and amortization	-97.87%1K	-27.66%34K	-4.66%184K	-6.52%43K	2.17%47K	-4.08%47K	-9.62%47K	0.52%193K	-66.42%46K	142.11%46K
Change In working capital	114.60%53K	-89.95%74K	57.32%-536K	-953.23%-653K	-158.59%-256K	-1,110.00%-363K	169.11%736K	-226.87%-1.26M	-107.83%-62K	-114.45%-99K
-Change in prepaid assets	38.44%-221K	46.18%459K	-2,550.00%-196K	-82.89%39K	-124.42%-190K	21.96%-359K	158.36%314K	-96.68%8K	-9.16%228K	-2.75%778K
-Change in payables and accrued expense	813.33%274K	-177.09%-350K	82.00%-205K	-154.65%-657K	96.21%-32K	-93.49%30K	191.35%454K	-231.68%-1.14M	-146.07%-258K	-1,026.67%-845K
-Change in other current liabilities	--0	-9.38%-35K	-8.00%-135K	-9.38%-35K	-6.25%-34K	-9.68%-34K	-6.67%-32K	-7.76%-125K	-68.42%-32K	20.00%-32K
Cash from discontinued investing activities
Operating cash flow	35.87%-1.78M	25.74%-2.01M	11.38%-10.75M	12.38%-2.37M	17.75%-2.9M	-14.08%-2.77M	21.94%-2.71M	-2.29%-12.13M	-9.47%-2.71M	-23.03%-3.53M
Investing cash flow
Cash flow from continuing investing activities			95.87%-5K	0	0			-137.25%-121K	0	76.67%-7K
Net PPE purchase and sale	----	----	95.87%-5K	--0	--0	----	----	-137.25%-121K	--0	76.67%-7K
Cash from discontinued investing activities
Investing cash flow	----	----	95.87%-5K	--0	--0	----	----	-137.25%-121K	--0	76.67%-7K
Financing cash flow
Cash flow from continuing financing activities	0	89.47%-4K	28,611.54%7.41M	120,050.00%2.4M	0	5.05M	-52.00%-38K	-100.12%-26K	300.00%2K	-3K
Net common stock issuance	--0	--0	--7.44M	--2.4M	--0	--5.05M	---11K	--0	--0	--0
Net preferred stock issuance	--0	--0	-200.00%-2K	--0	--0	--0	---2K	--2K	--2K	--0
Net other financing activities	--0	84.00%-4K	7.14%-26K	---1K	--0	--0	0.00%-25K	-2,700.00%-28K	--0	---3K
Cash from discontinued financing activities
Financing cash flow	--0	89.47%-4K	28,611.54%7.41M	120,050.00%2.4M	--0	--5.05M	-52.00%-38K	-100.12%-26K	300.00%2K	---3K
Net cash flow
Beginning cash position	-28.73%6.48M	-28.24%8.49M	-50.92%11.83M	-41.81%8.46M	-37.15%11.36M	-55.70%9.09M	-50.92%11.83M	68.65%24.11M	-45.32%14.53M	-38.69%18.07M
Current changes in cash	-178.21%-1.78M	26.62%-2.02M	72.78%-3.34M	101.22%33K	17.99%-2.9M	193.15%2.27M	23.68%-2.75M	-225.10%-12.28M	-9.34%-2.7M	-22.10%-3.54M
End cash Position	-58.63%4.7M	-28.73%6.48M	-28.24%8.49M	-28.24%8.49M	-41.81%8.46M	-37.15%11.36M	-55.70%9.09M	-50.92%11.83M	-50.92%11.83M	-45.32%14.53M
Free cash flow	35.99%-1.78M	25.74%-2.01M	12.21%-10.75M	12.38%-2.37M	17.92%-2.9M	-13.82%-2.78M	24.21%-2.71M	-2.86%-12.25M	-9.47%-2.71M	-22.00%-3.53M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data